Arcus Biosciences, Inc. (RCUS)
24.23
+0.64
(+2.71%)
USD |
NYSE |
Apr 17, 16:00
24.23
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Research and Development Expense (Quarterly) : 121.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.565B |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Sarepta Therapeutics, Inc. | 319.50M |